WEBSITECHANGES

Website Changes

---

06/27/2020

ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP

---

06/25/2020

A Systematic Review of Tumor Treating Fields Therapy for High-Grade Gliomas

---

06/24/2020

Musella Foundation Copay Program now closed to new patients

---

06/24/2020

New class of precision medicine strips cancer of its DNA defenses

---

06/24/2020

DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II

---

06/22/2020

Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease

---

06/21/2020

Brain Tumor Webinars continue tonight! Sunday 6/21/2020 7pm Eastern Time

---

06/18/2020

Gallagher, Colleagues Introduce Bipartisan Promising Pathways Act

---

06/15/2020

Karyopharm Announces Dosing of First Patient in a Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Patients with Newly Diagnosed or Recurrent Glioblastoma

---

06/15/2020

Global Post-Marketing Safety Surveillance of Tumor Treating Fields (TTFields) in Patients With High-Grade Glioma in Clinical Practice

---

06/15/2020

The Musella Foundation Awards 2 Brain Tumor Research Grants

---

06/15/2020

Cancer Vaccine Plus Adoptive T-cell Therapy Placed on Fast Track

---

06/13/2020

Brain Tumor Webinar Series continues tonight! 6/14/2020

---

06/13/2020

Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals` VAL-083 to Participate in the GBM AGILE Pivotal Study, an Adaptive Clinical Trial Platform in Glioblastoma Multiforme

---

06/07/2020

Brain Tumor Webinars continue tonight!

---

06/05/2020

The McDowell Family Lost A Child To Cancer And Now They Are Creating a Tourist Attraction to Fund Research– So Why Are Some Of The Neighbors So Angry?

---

06/02/2020

Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data

---

06/02/2020

First Patient Treated in Phase 1 Clinical Trial Of Incysus Therapeutics Gamma Delta (?d) T Cell Immunotherapy for Patients With Newly Diagnosed Glioblastoma

---

06/02/2020

Factors Affecting Survival in Glioblastoma: A 10-year Single-Center Experience From Saudi Arabia

---

06/01/2020

Phase 2a study to evaluate the safety, pharmacokinetics, and clinical activity of the PI3K / mTOR inhibitor GDC-0084 given to glioblastoma (GBM) patients with unmethylated MGMT promotor status

---

05/29/2020

ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG.

---

05/29/2020

Al Musella`s ASCO Hightlights

---

05/29/2020

Musella Foundation Awards Pediatric Brain Tumor Research Grant!

---

05/29/2020

Musella Foundation Copay Assistance program is running low on funding

---

05/29/2020

ASCO Brain Tumor Abstracts

---